- Home
- ALT vs NBR Comparison
ALT vs NBR Comparison
Compare ALT & NBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | NBR |
|---|---|---|
| Founded | 1997 | 1952 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.0M | 687.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ALT | NBR |
|---|---|---|
| Price | $5.41 | $53.75 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $16.33 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 3.5M | 397.5K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 14.43 |
| Revenue | $20,000.00 | ★ $3,116,983,000.00 |
| Revenue This Year | N/A | $9.62 |
| Revenue Next Year | N/A | $0.84 |
| P/E Ratio | ★ N/A | $3.79 |
| Revenue Growth | N/A | ★ 6.52 |
| 52 Week Low | $2.90 | $23.27 |
| 52 Week High | $9.59 | $69.20 |
Technical Indicators
Market Signals| Indicator | ALT | NBR |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 54.96 |
| Support Level | $5.03 | $54.74 |
| Resistance Level | $6.03 | $58.39 |
| Average True Range (ATR) | 0.38 | 2.79 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 53.39 | 61.00 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About NBR Nabors Industries Ltd.
Nabors Industries Ltd owns and operates land-based drilling rig fleets and is a provider of offshore platform rigs in the United States and international markets. It also provides performance tools, directional drilling services, tubular running services, and technologies. The company has four reportable segments: U.S. Drilling, International Drilling, Drilling Solutions, and Rig Technologies. The key revenue of the company is generated from International Drilling.